|
|||||
![]() |
|
1. Record Fiscal Q1 Revenue Sets Stage for the Year Ahead
First quarter fiscal 2026 revenue increased 22% to $10.9 million from $8.9 million last year – the strongest first quarter revenue on record for Roadzen, driven by growth in India and the U.S., along with the resumption of U.K. business opportunities.
2. Significantly Narrowed Net Loss and Fourth Straight Quarter of Adjusted EBITDA1 Improvement
Net loss narrowed to $(4.0) million from $(48.4) million in the first quarter last fiscal year, a 92% year-over-year improvement. Adjusted EBITDA loss improved to $(1.4) million from $(2.8) million the prior year — a 50% year-over-year improvement — marking the fourth consecutive quarter of sequential gains as the Company moves toward Adjusted EBITDA breakeven within this fiscal year.
3. Balance Sheet Strengthened Through Capital Raised at a Premium, Anchored by Roadzen’s Major Shareholders in July
Subsequent to the fiscal Q1 end, in the last week of July 2025, Roadzen closed two securities purchase transactions totaling approximately $4.5 million. The first transaction was priced at $1.25 per share, a 20% premium to market and led by Roadzen’s major shareholders; the second transaction was priced at $1.30 per share, both indicating strong investor confidence in the Company’s trajectory.
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company”), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the three-months ended June 30, 2025, its first quarter of fiscal year 2026.
“Roadzen delivered a record first quarter, with revenue up more than 22% year-over-year and our fourth consecutive quarter of improving Adjusted EBITDA, moving us significantly further along our path to breakeven,” said Rohan Malhotra, CEO and founder of Roadzen. “Q1 is typically our slowest quarter of the year due to seasonality, so this level of growth marks an important inflection point for us. The foundation we’ve built — stronger operations, a cleaner balance sheet, and a robust global client base — positions us to deliver the best year in our history.”
Malhotra continued, “We have multiple catalysts ahead, from the greenshoots in our U.K. business to regulatory tailwinds driving adoption of DrivebuddyAI in India, and expanding partnerships with some of the world’s largest insurers, automakers, and fleets as they choose Roadzen to bring AI to their operations. We believe the value we’re creating — through innovation, disciplined execution, and strategic growth — will be reflected in both our results and our market valuation. We ask investors to track three things this year: our growth on the path to breakeven, the continued strengthening of our balance sheet, and the innovations that reinforce our leadership as the leading AI company in insurance. This is a golden age of AI, and our mission is to power it — building solutions that transform the way mobility is insured worldwide.”
“This quarter’s results reflect the financial rigor and structural improvements we’ve worked hard to implement over the past year,” said Jean-Noël Gallardo, Chief Financial Officer of Roadzen. “We’ve significantly reduced operating expenses and brought more predictability to our financial model—all while supporting growth in strategic areas. Through a combination of disciplined cost management and targeted capital raises, we now have a clear path to reach Adjusted EBITDA breakeven.”
Mr. Gallardo added, “As our revenue base expands and costs remain controlled, we expect continued margin expansion and improved cash flow dynamics. We’re focused on maintaining this momentum and delivering sustainable, long-term value for our shareholders.”
First Fiscal Quarter 2026 Financial Highlights:
Revenue and Key Performance Indicators:
Operating Expenses:
Net Results:
Subsequent Financial Events:
First Quarter 2026 Operational Highlights
Product Advances and Patent Awards:
Contract Announcement:
Subsequent Fiscal 2026 Operational Developments
Contract and Partnership Announcements:
General Interest:
For more information about Roadzen Inc., please visit https://roadzen.ai/
About Roadzen Inc.
Roadzen Inc. (Nasdaq: RDZN) is a global technology company transforming auto insurance using advanced artificial intelligence (AI). Thousands of clients, from the world’s leading insurers, carmakers, and fleets to dealerships and auto insurance agents, use Roadzen’s technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics, generative AI, and computer vision has earned recognition as a top AI innovator by publications such as Forbes, Fortune, and Financial Express. Roadzen’s mission is to continue advancing AI research at the intersection of mobility and insurance, ushering in a world where accidents are prevented, premiums are fair, and claims are processed within minutes, not weeks. Headquartered in Burlingame, California, the Company has 323 employees across its global offices in the U.S., U.K. and India. To learn more, please visit www.roadzen.ai.
Cautionary Statement Regarding Forward Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, anticipated benefits and revenues from the partnership described in this press release, business growth in the U.S., U.K. and India, anticipated Adjusted EBITDA breakeven timing, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the annual report on Form 10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information, please contact:
Investor Contacts: [email protected]
Media Contacts: Sanya Soni [email protected] or [email protected]
***Financial Statements Follow ***
Roadzen Inc. Unaudited Condensed Consolidated Balance Sheets (in US $, except share count) | ||||||||
As of June 30, | As of March 31, | |||||||
Particulars | 2025 | 2025 | ||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | 3,124,856 | 4,836,576 | ||||||
Accounts receivable, net | 2,574,592 | 2,625,385 | ||||||
Inventories | 99,187 | 202,535 | ||||||
Prepayments and other current assets | 21,167,240 | 19,092,595 | ||||||
Investments | 124,689 | 197,805 | ||||||
Total current assets | 27,090,564 | 26,954,896 | ||||||
Non current assets | ||||||||
Restricted cash | 218,714 | 217,064 | ||||||
Non marketable securities | 269,470 | 269,470 | ||||||
Property and equipment, net | 633,015 | 602,923 | ||||||
Goodwill | 2,061,553 | 2,061,553 | ||||||
Operating lease right-of-use assets | 1,048,594 | 1,109,219 | ||||||
Intangible assets, net | 1,504,567 | 1,243,253 | ||||||
Other long-term assets | 130,822 | 120,972 | ||||||
Total Non current assets | 5,866,735 | 5,624,454 | ||||||
Total assets | 32,957,299 | 32,579,350 | ||||||
Liabilities and shareholders’ Equity/(Deficit) | ||||||||
Current liabilities | ||||||||
Current portion of long-term borrowings | 2,912,746 | 2,904,444 | ||||||
Short-term borrowings | 20,591,106 | 19,865,645 | ||||||
Accounts payable and accrued expenses | 32,822,637 | 30,254,010 | ||||||
Derivative warrant liabilities | 1,535,869 | 1,489,818 | ||||||
Short-term operating lease liabilities | 442,914 | 318,921 | ||||||
Other current liabilities | 2,304,421 | 2,102,466 | ||||||
Total current liabilities | 60,609,693 | 56,935,304 | ||||||
Non current liabilities | ||||||||
Long-term borrowings | 150,334 | 139,775 | ||||||
Long-term operating lease liabilities | 443,500 | 628,400 | ||||||
Other long-term liabilities | 547,523 | 566,651 | ||||||
Total Non current liabilities | 1,141,357 | 1,334,826 | ||||||
Total liabilities | 61,751,050 | 58,270,130 | ||||||
Commitments and contingencies (refer note 21) | ||||||||
Shareholders’ Equity/(Deficit) | ||||||||
Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of June 30, 2025 and March 31, 2025; 74,290,986 shares outstanding as of June 30, 2025 and March 31, 2025 | 96,888,250 | 95,501,291 | ||||||
Accumulated deficit | (227,832,212 | ) | (223,826,442 | ) | ||||
Accumulated other comprehensive income/(loss) | (929,924 | ) | (468,859 | ) | ||||
Other components of equity | 103,791,466 | 103,720,113 | ||||||
Total shareholders’ deficit | (28,082,420 | ) | (25,073,897 | ) | ||||
Non-controlling interest | (711,331 | ) | (616,883 | ) | ||||
Total deficit | (28,793,751 | ) | (25,690,780 | ) | ||||
Total liabilities and Total Deficit | 32,957,299 | 32,579,350 | ||||||
Roadzen Inc. Unaudited Condensed Consolidated Statements of Operations (in US $, except share count) | ||||||||
For the three months ended June 30, | ||||||||
Particulars | 2025 | 2024 | ||||||
Revenue | 10,865,545 | 8,931,517 | ||||||
Costs and expenses: | ||||||||
Cost of services | 4,469,453 | 5,427,440 | ||||||
Research and development | 81,534 | 1,789,542 | ||||||
Sales and marketing | 6,132,010 | 5,802,298 | ||||||
General and administrative | 2,577,897 | 25,826,188 | ||||||
Depreciation and amortization | 125,000 | 480,349 | ||||||
Total costs and expenses | 13,385,894 | 39,325,817 | ||||||
Loss from operations | (2,520,349 | ) | (30,394,300 | ) | ||||
Interest expense (net) | (941,319 | ) | (821,686 | ) | ||||
Fair value gains/(losses) in financial instruments carried at fair value | (511,538 | ) | (17,152,060 | ) | ||||
Other income (net) | (47,922 | ) | 22,352 | |||||
Total other income/(expense) | (1,500,779 | ) | (17,951,394 | ) | ||||
(Loss)/Income before income tax expense | (4,021,128 | ) | (48,345,694 | ) | ||||
Less: income tax (benefit)/expense | 79,979 | 106,650 | ||||||
Net (loss)/income before non-controlling interest | (4,101,107 | ) | (48,452,344 | ) | ||||
Net loss attributable to non-controlling interest, net of tax | (95,337 | ) | (45,319 | ) | ||||
Net Loss attributable to Ordinary shareholders | (4,005,770 | ) | (48,407,025 | ) | ||||
Net loss per share attributable to Ordinary shareholders | ||||||||
Basic and Diluted | (0.05 | ) | (0.71 | ) | ||||
Weighted-average number of shares used in computing net loss per share (Basic and Diluted) | 74,290,986 | 68,440,829 | ||||||
Roadzen Inc. Unaudited Condensed Consolidated Statements of Cash Flow (in US $, except share count) | ||||||||
For the Period ended June 30, | ||||||||
Particulars | 2025 | 2024 | ||||||
Cash flows from operating activities | ||||||||
Net loss per share attributable to Ordinary shareholders | (4,005,770 | ) | (48,407,025 | ) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 125,000 | 480,349 | ||||||
Stock based compensation | 71,358 | 26,230,989 | ||||||
Deferred income taxes | (1,289 | ) | (37,185 | ) | ||||
Unrealized foreign exchange loss/(profit) | (9,456 | ) | (3,398 | ) | ||||
Fair value losses in financial instruments carried at fair value | 511,538 | 17,152,060 | ||||||
Expected credit loss (net of reversal) | 198,749 | (50,682 | ) | |||||
Net loss attributable to non-controlling interest, net of tax | (95,337 | ) | (45,319 | ) | ||||
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | ||||||||
Inventories | 103,415 | (6,803 | ) | |||||
Accounts receivables, net | (147,930 | ) | 1,037,883 | |||||
Prepayments and other assets | (2,071,468 | ) | 1,046,454 | |||||
Accounts payable and accrued expenses | 2,323,205 | (2,767,021 | ) | |||||
Other liabilities | 76,478 | (296,982 | ) | |||||
Net cash used in operating activities | (2,921,507 | ) | (5,666,680 | ) | ||||
Cash flows from investing activities | ||||||||
Purchase of property and equipment, intangible assets and goodwill | (274,056 | ) | 32,745 | |||||
Proceeds from sale of mutual fund | 73,116 | 193,606 | ||||||
Proceeds from forward purchase agreement | - | 1,000,000 | ||||||
Net cash used in investing activities | (200,940 | ) | 1,226,351 | |||||
Cash flows from financing activities | ||||||||
Proceeds from issue of ordinary shares | 1,386,959 | - | ||||||
Net proceeds/(payments) from borrowings | 49,990 | - | ||||||
Repayments of long-term borrowings | - | (121,365 | ) | |||||
Net proceeds/(payments) from short-term borrowings | - | 1,154,519 | ||||||
Net cash generated from financing activities | 1,436,949 | 1,033,154 | ||||||
Effect of exchange rate changes on cash and cash equivalents | (24,586 | ) | (3,519 | ) | ||||
Net (decrease)/increase in cash and cash equivalents (including restricted cash) | (1,710,084 | ) | (3,410,694 | ) | ||||
Cash and cash equivalents at the beginning of the period (including restricted cash) | 5,053,654 | 11,565,088 | ||||||
Cash and cash equivalents at the end of the period (including restricted cash) | 3,343,570 | 8,154,394 | ||||||
Reconciliation of cash and cash equivalents | ||||||||
Cash and cash equivalents | 3,124,856 | 7,777,413 | ||||||
Restricted cash | 218,714 | 376,981 | ||||||
Total cash and cash equivalents | 3,343,570 | 8,154,394 | ||||||
Supplemental disclosure of cash flow information | ||||||||
Cash paid for interest, net of amounts capitalized | 1,001,397 | 391,829 | ||||||
Non-cash investing and financing activities | ||||||||
Consideration payable in connection with acquisitions | 8,376,253 | 488,000 | ||||||
Interest accrued on borrowings | 2,089,465 | 790,395 | ||||||
Non-GAAP Financial Measures
This press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (“Adjusted EBITDA”), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain non-recurring and other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flows provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.
The following table reconciles our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:
For the three months ended June 30, | ||||||||
Particulars | 2025 | 2024 | ||||||
Net loss (Including Non Controlling Interest) | (4,005,770 | ) | (48,407,025 | ) | ||||
Adjusted for: | ||||||||
Other (income)/expense net | 47,922 | (22,352 | ) | |||||
Interest (income)/expense | 941,319 | 821,686 | ||||||
Fair value changes in financial instruments carried at fair value | 511,538 | 17,152,060 | ||||||
Tax (benefit)/expense | 79,979 | 106,650 | ||||||
Depreciation and amortization | 125,000 | 480,349 | ||||||
Stock based compensation expense | 71,358 | 26,230,989 | ||||||
Non-cash expenses | 306,714 | 285,060 | ||||||
Non-recurring expenses | 516,102 | 524,758 | ||||||
Adjusted EBITDA | (1,405,838 | ) | (2,827,825 | ) |
1 Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.
Aug-18 | |
Aug-18 | |
Aug-13 | |
Aug-07 | |
Jul-31 | |
Jul-28 | |
Jul-24 | |
Jul-17 | |
Jul-16 | |
Jul-15 | |
Jun-26 | |
Jun-17 | |
Jun-03 | |
May-28 | |
May-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite